MetLife Investment Management’s Axonics, Inc. Common Stock AXNX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-29,422
| Closed | -$2.05M | – | 2880 |
|
|
2024
Q3 | $2.05M | Hold |
29,422
| – | – | 0.01% | 1004 |
|
|
2024
Q2 | $1.98M | Buy |
29,422
+3,841
| +15% | +$258K | 0.01% | 977 |
|
|
2024
Q1 | $1.76M | Sell |
25,581
-614
| -2% | -$42.3K | 0.01% | 1007 |
|
|
2023
Q4 | $1.63M | Hold |
26,195
| – | – | 0.01% | 1037 |
|
|
2023
Q3 | $1.47M | Hold |
26,195
| – | – | 0.01% | 1040 |
|
|
2023
Q2 | $1.32M | Buy |
26,195
+224
| +0.9% | +$11.3K | 0.01% | 1118 |
|
|
2023
Q1 | $1.42M | Hold |
25,971
| – | – | 0.01% | 1051 |
|
|
2022
Q4 | $1.62M | Hold |
25,971
| – | – | 0.01% | 991 |
|
|
2022
Q3 | $1.83M | Buy |
25,971
+1,234
| +5% | +$86.9K | 0.02% | 919 |
|
|
2022
Q2 | $1.4M | Hold |
24,737
| – | – | 0.01% | 1048 |
|
|
2022
Q1 | $1.55M | Buy |
24,737
+8,782
| +55% | +$550K | 0.01% | 1101 |
|
|
2021
Q4 | $893K | Hold |
15,955
| – | – | 0.01% | 1177 |
|
|
2021
Q3 | $1.04M | Buy |
15,955
+942
| +6% | +$61.3K | 0.01% | 1103 |
|
|
2021
Q2 | $952K | Buy |
15,013
+3,367
| +29% | +$214K | 0.01% | 1186 |
|
|
2021
Q1 | $697K | Sell |
11,646
-2,145
| -16% | -$128K | 0.01% | 1335 |
|
|
2020
Q4 | $688K | Hold |
13,791
| – | – | 0.01% | 1314 |
|
|
2020
Q3 | $704K | Hold |
13,791
| – | – | 0.01% | 1203 |
|
|
2020
Q2 | $484K | Buy |
13,791
+6,323
| +85% | +$222K | 0.01% | 1397 |
|
|
2020
Q1 | $190K | Hold |
7,468
| – | – | ﹤0.01% | 1729 |
|
|
2019
Q4 | $207K | Hold |
7,468
| – | – | ﹤0.01% | 1961 |
|
|
2019
Q3 | $201K | Hold |
7,468
| – | – | ﹤0.01% | 1942 |
|
|
2019
Q2 | $306K | Buy |
+7,468
| New | +$306K | ﹤0.01% | 1774 |
|